Source comparison
How to Inject PT-141 SubQ: Equipment Comparison
Needle Gauge 27G, 29G, or 30G Balances flow rate with tissue trauma. 29G is optimal for most users 29-gauge provides the best compromise between injection speed and patient comfort; 30-gauge requires excessive pressure for viscous solutions Needle Length 0.5 i
This comparison does not assign a generated winner or score.
- Needle Gauge
- 27G, 29G, or 30G
- Balances flow rate with tissue trauma. 29G is optimal for most users
- 29-gauge provides the best compromise between injection speed and patient comfort; 30-gauge requires excessive pressure for viscous solutions
- Needle Length
- 0.5 inch (12.7mm)
- Ensures adequate penetration depth for subcutaneous layer without reaching muscle
- 0.5-inch needles at 45° deliver peptide to the hypodermis with minimal risk of intramuscular injection
- Syringe Volume
- 0.5mL or 1mL insulin syringe
- Allows precise measurement in 0.01mL increments
- U-100 insulin syringes are marked in units that correspond to 0.01mL per unit. Essential for peptide dosing accuracy
- Reconstitution Ratio
- 2mL bacteriostatic water per 10mg PT-141
- Produces 5mg/mL concentration, allowing small injection volumes
- 5mg/mL concentration means a 1.75mg dose = 0.35mL, which is easy to measure and minimizes injection volume discomfort
- Injection Angle
- 45 degrees
- Targets subcutaneous adipose layer at 4–6mm depth
- Shallower angles risk intradermal injection; steeper angles risk intramuscular depth. 45° is the anatomical standard